Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Arctiin is a lignan compound found primarily in the seeds of Arctium lappa (burdock). Recent preclinical studies have investigated the potential of arctiin in supporting bone health, particularly in the context of osteoporosis. Laboratory (in vitro) and animal (in vivo) research indicates that arctiin may promote osteoblast differentiation and inhibit osteoclast activity, processes that are crucial for bone formation and resorption, respectively. For example, a study published in Phytomedicine (2018) demonstrated that arctiin stimulated osteoblastic cells and suppressed osteoclastogenesis in mouse models, suggesting a possible preventative effect against bone loss. Another animal study found that arctiin administration mitigated bone loss in ovariectomized rats, a common model for postmenopausal osteoporosis. However, there are no robust clinical trials in humans evaluating arctiin’s efficacy or safety for osteoporosis treatment or prevention. Evidence is thus limited to laboratory and animal models, which may not fully translate to human outcomes. There is also no strong tradition of arctiin or burdock seed use specifically for osteoporosis in traditional medicine literature. In summary, while scientific interest is growing and preclinical evidence is promising, the overall level of evidence remains low, and arctiin should not be considered a validated therapy for osteoporosis pending further research.

More about arctiin
More about Osteoporosis

Other ingredients used for Osteoporosis

Other health conditions supported by arctiin

Products containing arctiin